Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents.
about
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialA minimal fragment of MUC1 mediates growth of cancer cellsMUC1* mediates the growth of human pluripotent stem cellsThe MUC1 extracellular domain subunit is found in nuclear speckles and associates with spliceosomesCooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesisMUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damageInhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPHMUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated MechanismMucins in cancer: function, prognosis and therapyMicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1Lung cancer vaccinesMUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitroCharacterization of the MUC1-C Cytoplasmic Domain as a Cancer TargetMUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cellsMUC1 expression by human airway epithelial cells mediates Pseudomonas aeruginosa adhesion.Protection of cisplatin cytotoxicity by an inactive cyclin-dependent kinase.Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles.O-glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines.MUC1 mucin interacts with calcium-modulating cyclophilin ligand.MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patientsCooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.Mucin 1 C-terminal subunit oncoprotein is a target for small-molecule inhibitors.The cytoplasmic domain of MUC1 induces hyperplasia in the mammary gland and correlates with nuclear accumulation of β-catenin.Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasionRNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cellsMuc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen.Intrinsic mitochondrial membrane potential and associated tumor phenotype are independent of MUC1 over-expression.Survival of human multiple myeloma cells is dependent on MUC1 C-terminal transmembrane subunit oncoprotein function.Impact of MUC1 mucin downregulation in the phenotypic characteristics of MKN45 gastric carcinoma cell lineMUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIRProtein mislocalization: mechanisms, functions and clinical applications in cancer.MUC1-C Oncoprotein Interacts Directly with ATM and Promotes the DNA Damage Response to Ionizing Radiation.EGFR-mediated carcinoma cell metastasis mediated by integrin αvβ5 depends on activation of c-Src and cleavage of MUC1.Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.Altered Mucins (MUC) trafficking in benign and malignant conditions.MUC1c regulates cell survival in pancreatic cancer by preventing lysosomal permeabilization.MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.
P2860
Q21261279-DAC054A2-51EA-4670-8148-604A99AFF312Q21562292-674722C1-655D-40DE-BAFC-73066491720BQ21562511-D37BBF91-FFCA-4A42-BA20-E8BCB697F188Q24297035-0AB9F8BD-75AC-425D-95F6-AF7AE47A7544Q24298462-FEE20447-6936-40C7-B7CC-164C9472AC5EQ24298896-D60DE93A-B1DF-42B6-A23F-0DAF2A7BC83BQ24603767-A477B2F4-7D1C-41C8-B1C5-36C6ECDDD702Q24626837-EA6645B6-2800-4D2D-95BF-D15E3CD79AD4Q24633765-FF4C479C-B613-4509-8369-1A4E430089C0Q24647663-D149E8C8-5505-4A8E-BC1E-B962BCCB6793Q27014375-C9231A5E-31A1-4435-84F7-8810A537AFFFQ28271920-EFCE6CEC-961E-4607-95D9-86AFE3D2A9C1Q28481099-B8D2B89B-AD65-4576-842E-269E34270FDEQ28547180-18146674-FCFE-438C-A0EB-76623AD9B192Q28742196-2EAE5D08-9BF5-46BF-A4DF-91D7FD66B461Q30417890-DF836434-DD74-4366-9BDD-AD7EFE2786BBQ30495496-204A7AB8-067D-44C5-966F-432AB30F512EQ33217688-CFE6DF70-ADDD-4EFF-8B5D-431F4599B796Q33397243-B26DB52A-37E1-456E-9370-81F990FBF722Q33398890-94A7B9B3-1686-46D6-8A1F-4E432D0BEF25Q33574955-34DF5C70-1317-49B4-BF18-3739F614B64AQ33647653-4FAC422B-1B9C-4D8B-8CDD-47423B2A6E90Q33757061-C9BFF5B5-208C-46D8-8604-F013AF26B642Q33827824-214A2500-15FD-446E-A0B8-4BD458742D01Q33886076-69B62B61-1F1D-46FE-BE51-3BC72BC7307EQ33888309-11B0265C-7E02-4B16-863B-49EA48F58B57Q33901817-8F0BC2D3-8973-4E68-BDAA-6E0516165B6BQ33946423-135C32C3-DD2C-41B4-BA15-4FC244025EB1Q33967077-100FC44A-8D2F-44E6-8B27-9F8BD0AF2626Q34038061-8F630DF9-D1AE-46C3-947C-7E2775892575Q34051633-68C1384D-21A1-46CC-BA48-B37AD9D3E868Q34071695-18C27F4C-F788-4B99-8820-92E2C1A5059CQ34073802-91C0BA1C-0C70-4A7C-96F3-3B765D3F4D12Q34076405-F6C25B2B-EC0D-4CD6-AFA8-775EF6349555Q34145187-433A19D7-1A7A-411D-8A5D-8483E7BDB00AQ34269196-5C4DCA22-B326-4DC8-A7E3-477EBFE2EED0Q34345106-42430023-0567-4D11-9EE0-6409FB020030Q34365646-F9B13A57-79FE-4A9E-BBA0-60FC24207914Q34389169-5AD542FE-AFCD-4F29-9359-62DBB5A741DBQ34405157-E6EFE81F-F12E-4CBC-A335-C792B38749B5
P2860
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Human MUC1 carcinoma-associate ...... o genotoxic anticancer agents.
@ast
Human MUC1 carcinoma-associate ...... o genotoxic anticancer agents.
@en
Human MUC1 carcinoma-associate ...... o genotoxic anticancer agents.
@nl
type
label
Human MUC1 carcinoma-associate ...... o genotoxic anticancer agents.
@ast
Human MUC1 carcinoma-associate ...... o genotoxic anticancer agents.
@en
Human MUC1 carcinoma-associate ...... o genotoxic anticancer agents.
@nl
prefLabel
Human MUC1 carcinoma-associate ...... o genotoxic anticancer agents.
@ast
Human MUC1 carcinoma-associate ...... o genotoxic anticancer agents.
@en
Human MUC1 carcinoma-associate ...... o genotoxic anticancer agents.
@nl
P2093
P2860
P1433
P1476
Human MUC1 carcinoma-associate ...... o genotoxic anticancer agents.
@en
P2093
Deepak Raina
Donald Kufe
Dongshu Chen
Naoki Agata
Surender Kharbanda
Wei-hsuan Yu
Yongqing Li
P2860
P304
P356
10.1016/S1535-6108(04)00020-0
P577
2004-02-01T00:00:00Z